| Products/Services Used | Details | Operation |
|---|---|---|
| Catalog Antibodies> | were blocked with 1% BSA-PBST for 30 min and incubated with primary antibodies, anti- H2AX (1:500, Novus Biologicals, NB100-384) and anti-c-Myc (1:500, GenScript, A00704), at 4 C overnight. Primary antibodies were aspirated and replaced with 1 PBS for a 3 5 min rinse. Cells were then incubated with Alexa at 95 C for 5 min. Primary antibodies RD4 (1:250, MilliporeSigma, 05 804), anti- -tubulin (1:400, Novus Biologicals, NB600-936), anti-c-Myc (1:500, GenScript, A00704) and anti-GAPDH (1:25, Novus Biologicals, NB300-221) were diluted with Antibody Diluent 2 (ProteinSimple). Secondary antibodies (anti-mouse or | Get A Quote |
Sporadic Alzheimer s disease and some forms of frontotemporal lobar degeneration (FTLD-tau) are neurological disorders of later life where cognitive deficits follow from the progressive accumulation of microtubule-associated tau protein. Disease-related tau accumulation is marked by altered subcellular distribution and rearrangement of this natively unstructured protein into alternative conformational forms, including highly organized fibrillar assemblies. With a partial analogy to effects seen in prion diseases, pathological tau conformers have a templating activity called seeding that may be measured in cellular and cell-free systems. Moreover, cellular systems and disease models can recapitulate strain effec... More